First Header Logo Second Header Logo

Connection

Anthony Atala to Cisplatin

This is a "connection" page, showing publications Anthony Atala has written about Cisplatin.
Connection Strength

1.284
  1. Atala A. Re: Carvedilol efficiently protects kidneys without affecting the antitumor efficacy of cisplatin in mice. J Urol. 2014 Aug; 192(2):614.
    View in: PubMed
    Score: 0.485
  2. Atala A. Re: enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfecting the attenuated salmonella carrying a plasmid co-expressing p53 gene and MDM2 siRNA. J Urol. 2014 Mar; 191(3):866-7.
    View in: PubMed
    Score: 0.469
  3. Ding B, Sun G, Liu S, Peng E, Wan M, Chen L, Jackson J, Atala A. Three-Dimensional Renal Organoids from Whole Kidney Cells: Generation, Optimization, and Potential Application in Nephrotoxicology In Vitro. Cell Transplant. 2020 Jan-Dec; 29:963689719897066.
    View in: PubMed
    Score: 0.179
  4. Rota C, Imberti B, Pozzobon M, Piccoli M, De Coppi P, Atala A, Gagliardini E, Xinaris C, Benedetti V, Fabricio AS, Squarcina E, Abbate M, Benigni A, Remuzzi G, Morigi M. Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev. 2012 Jul 20; 21(11):1911-23.
    View in: PubMed
    Score: 0.103
  5. Guo H, Deng N, Dou L, Ding H, Criswell T, Atala A, Furdui CM, Zhang Y. 3-D Human Renal Tubular Organoids Generated from Urine-Derived Stem Cells for Nephrotoxicity Screening. ACS Biomater Sci Eng. 2020 12 14; 6(12):6701-6709.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.